Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Lars Tatenhorst, Katrin Eckermann, Vivian Dambeck, et al.
Acta Neuropathologica Communications (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 140

Showing 26-50 of 140 citing articles:

Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation
Eleonora Carboni, Lars Tatenhorst, Lars Tönges, et al.
NeuroMolecular Medicine (2017) Vol. 19, Iss. 2-3, pp. 309-321
Open Access | Times Cited: 53
Role of RhoA-ROCK signaling in Parkinson's disease
Mahalaxmi Iyer, Mohana Devi Subramaniam, Dhivya Venkatesan, et al.
European Journal of Pharmacology (2020) Vol. 894, pp. 173815-173815
Closed Access | Times Cited: 49
Chemical Chaperones as Novel Drugs for Parkinson’s Disease
Jordi Pujols, Samuel Peña‐Díaz, Irantzu Pallarès, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 4, pp. 408-421
Closed Access | Times Cited: 48
Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
Friederike Ostendorf, Judith Metzdorf, Ralf Gold, et al.
Molecules (2020) Vol. 25, Iss. 11, pp. 2502-2502
Open Access | Times Cited: 40
Perspectives on ROCK2 as a Therapeutic Target for Alzheimer’s Disease
Audrey J. Weber, Jeremy H. Herskowitz
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 37
Parkinson’s disease therapy: what lies ahead?
Andreas Wolff, Nicolas U Schumacher, Dominik Pürner, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 793-820
Open Access | Times Cited: 13
Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein
Pavel I. Semenyuk
Biophysical Chemistry (2024) Vol. 307, pp. 107196-107196
Closed Access | Times Cited: 5
Small molecule modulators of Alpha-Synuclein Aggregation and Toxicity: Pioneering an Emerging Arsenal Against Parkinson’s Disease
Ishfaq Ahmad Ahanger, Tanveer Ali Dar
Ageing Research Reviews (2024) Vol. 101, pp. 102538-102538
Closed Access | Times Cited: 5
New insights on the regulators and inhibitors of RhoA-ROCK signalling in Parkinson’s disease
Nandita Ravichandran, Mahalaxmi Iyer, Deenathayalan Uvarajan, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
LncRNA NEAT1, an Important Biomarker Involved in the Pathological and Physiological Processes of Parkinson's Disease
Runsen Chen, Yuxi Zhang, Yang Shen, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms
Lucia Lage, Ana I. Rodríguez‐Pérez, José L. Labandeira‐García, et al.
Neurotherapeutics (2025), pp. e00544-e00544
Open Access
Involvement of RhoA/ROCK Signaling Pathway in Methamphetamine-Induced Blood-Brain Barrier Disruption
Jong Su Hwang, Tam Thuy Lu Vo, Mi Kyung Kim, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 340-340
Open Access
Alpha-synuclein and iron: two keys unlocking Parkinson’s disease
Paul Lingor, Eleonora Carboni, Jan Christoph Koch
Journal of Neural Transmission (2017) Vol. 124, Iss. 8, pp. 973-981
Closed Access | Times Cited: 43
Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis
Alexandra Stanley, Su-Jin Heo, Robert L. Mauck, et al.
Journal of Bone and Mineral Research (2019) Vol. 34, Iss. 10, pp. 1894-1909
Open Access | Times Cited: 41
Interventions Targeting Glucocorticoid-Krüppel-like Factor 15-Branched-Chain Amino Acid Signaling Improve Disease Phenotypes in Spinal Muscular Atrophy Mice
Lisa Walter, Marc‐Olivier Deguise, Katharina E. Meijboom, et al.
EBioMedicine (2018) Vol. 31, pp. 226-242
Open Access | Times Cited: 39
Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
Yasushi Yabuki, Kazuya Matsuo, K. Kawahata, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2230-2230
Open Access | Times Cited: 38
Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein
Mingming Xu, Philip Ryan, Santosh Rudrawar, et al.
Acta Pharmacologica Sinica (2019) Vol. 41, Iss. 4, pp. 483-498
Open Access | Times Cited: 36
Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson’s disease
Makoto Hideshima, Yasuyoshi Kimura, César Aguirre, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Rational drug design targeting intrinsically disordered proteins
H. Wang, Ruoyao Xiong, Luhua Lai
Wiley Interdisciplinary Reviews Computational Molecular Science (2023) Vol. 13, Iss. 6
Closed Access | Times Cited: 12
Evidence of α-Synuclein/Glucocerebrosidase Dual Targeting by Iminosugar Derivatives
Giuseppe Tagliaferro, Maria Giulia Davighi, Francesca Clemente, et al.
ACS Chemical Neuroscience (2025)
Open Access
Rho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential after Disease Onset
René Günther, Alexander Balck, Jan Christoph Koch, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 38
Distinct and complementary functions of rho kinase isoforms ROCK1 and ROCK2 in prefrontal cortex structural plasticity
Kelsey M. Greathouse, Benjamin D. Boros, Josue F. Deslauriers, et al.
Brain Structure and Function (2018) Vol. 223, Iss. 9, pp. 4227-4241
Open Access | Times Cited: 33
ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization
Samuel Peña‐Díaz, Jordi Pujols, María Conde-Giménez, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 33
The CatWalk XT® is a valid tool for objective assessment of motor function in the acute phase after controlled cortical impact in mice
Johannes Walter, Olga Kovalenko, Alexander Younsi, et al.
Behavioural Brain Research (2020) Vol. 392, pp. 112680-112680
Closed Access | Times Cited: 29
Emerging targets in drug discovery against neurodegenerative diseases: Control of synapsis disfunction by the RhoA/ROCK pathway
Olmo Martín-Cámara, Ángel Cores, Pilar López‐Alvarado, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113742-113742
Closed Access | Times Cited: 26

Scroll to top